Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Kinase inhibitor")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 6499

  • Page / 260
Export

Selection :

  • and

Synthesis and biological evaluation of N-arylbenzo[b]thieno[3,2-d]pyrimidin-4-amines and their pyrido and pyrazino analogues as Ser/Thr kinase inhibitorsLOIDREAU, Yvonnick; MARCHAND, Pascal; DUBOUILH-BENARD, Carole et al.European journal of medicinal chemistry. 2012, Vol 58, pp 171-183, issn 0223-5234, 13 p.Article

The Substrate-Activity-Screening methodology applied to receptor tyrosine kinases: A proof-of-concept studyCHAPELAT, Julien; BERST, Frederic; MARZINZIK, Andreas L et al.European journal of medicinal chemistry. 2012, Vol 57, pp 1-9, issn 0223-5234, 9 p.Article

Hormone-sensitive lipase activity and triacylglycerol hydrolysis are decreased in rat soleus muscle by cyclopiazonic acidWATT, Matthew J; STEINBERG, Gregory R; HEIGENHAUSER, G. J. F et al.American journal of physiology. Endocrinology and metabolism. 2003, Vol 48, Num 2, pp E412-E419, issn 0193-1849Article

Indole RSK inhibitors. Part 1: Discovery and initial SARBOYER, Stephen J; BURKE, Jennifer; DICAPUA, Frank et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 1, pp 733-737, issn 0960-894X, 5 p.Article

Identification of novel, potent and selective inhibitors of Polo-like kinase 1SHAOQING CHEN; BARTKOVITZ, David; NADERI-OBOODI, Goli et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 2, pp 1247-1250, issn 0960-894X, 4 p.Article

Small molecule inhibitors of BRAF in clinical trialsZAMBON, Alfonso; NICULESCU-DUVAZ, Ion; NICULESCU-DUVAZ, Dan et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 2, pp 789-792, issn 0960-894X, 4 p.Article

Indole RSK inhibitors. Part 2: Optimization of cell potency and kinase selectivityKIRRANE, Thomas M; BOYER, Stephen J; KUGLER, Stanley et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 1, pp 738-742, issn 0960-894X, 5 p.Article

Involvement of spinal tyrosine kinase in inflammatory and N-methyl-D-aspartate-induced hyperalgesia in ratsSATO, Eiru; TAKANO, Yoshito; KUNO, Yuichiro et al.European journal of pharmacology. 2003, Vol 468, Num 3, pp 191-198, issn 0014-2999, 8 p.Article

Protein kinase Cα and ε small-molecule targeted therapeutics : a new roadmap to two Holy Grails in drug discovery?O'BRIAN, Catherine A; FENG CHU; BORNMANN, William G et al.Expert review of anticancer therapy. 2006, Vol 6, Num 2, pp 175-186, issn 1473-7140, 12 p.Article

In vitro and In vivo pharmacokinetic-pharmacodynamic relationships for the trisubstituted aminopurine cyclin-dependent kinase inhibitors olomoucine, bohemine and CYC202RAYNAUD, Florence I; WHITTAKER, Steven R; VALENTI, Melanie et al.Clinical cancer research. 2005, Vol 11, Num 13, pp 4875-4888, issn 1078-0432, 14 p.Article

Third-Generation Tyrosine Kinase Inhibitors and BeyondQUINTAS-CARDAMA, Alfonso; KANTARJIAN, Hagop; CORTES, Jorge et al.Seminars in hematology. 2010, Vol 47, Num 4, pp 371-380, issn 0037-1963, 10 p.Article

The function of cyclin-dependent kinase inhibitor p21Cip-1/SDI-1-WAF-1 in chondrogenic differentiationNEGISHI, Yoichi; KAWASHIMA, Kohtaro.Recent research developments in biophysics and biochemistry vol. 4 - 2004 Part I. Recent research developments in biophysics and biochemistry. 2004, pp 175-187, isbn 81-7736-214-3, 13 p.Book Chapter

Molecular Pathways: Resistance to Kinase Inhibitors and Implications for Therapeutic StrategiesLOVLY, Christine M; SHAW, Alice T.Clinical cancer research (Print). 2014, Vol 20, Num 9, pp 2249-2256, issn 1078-0432, 8 p.Article

Nilotinib: A Novel, Selective Tyrosine Kinase InhibitorBLAY, Jean-Yves; VON MEHREN, Margaret.Seminars in oncology. 2011, Vol 38, Num 2, issn 0093-7754, S3-S9, SUP1Article

NilotinibDEININGER, Michael W.Clinical cancer research. 2008, Vol 14, Num 13, pp 4027-4031, issn 1078-0432, 5 p.Article

A RHO KINASE (ROCK) INHIBITOR, FASUDIL, PREVENTS MATRIX METALLOPROTEINASE-9-RELATED HEMORRHAGIC TRANSFORMATION IN MICE TREATED WITH TISSUE PLASMINOGEN ACTIVATORISHIGURO, M; KAWASAKI, K; IWAMA, T et al.Neuroscience. 2012, Vol 220, pp 302-312, issn 0306-4522, 11 p.Article

Rationale and clinical basis for combining gefitinib (IRESSA, ZD1839) with radiation therapy for solid tumorsOCHS, Judith S.International journal of radiation oncology, biology, physics. 2004, Vol 58, Num 3, pp 941-949, issn 0360-3016, 9 p.Conference Paper

Tyrosine kinase inhibitor STI-571/gleevec down-regulates the β-catenin signaling activityLAN ZHOU; AN, Naili; JAE YOON PARKA et al.Cancer letters. 2003, Vol 193, Num 2, pp 161-170, issn 0304-3835, 10 p.Article

Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitorsBIANCO, Roberto; INCHEOL SHIN; RITTER, Christoph A et al.Oncogene (Basingstoke). 2003, Vol 22, Num 18, pp 2812-2822, issn 0950-9232, 11 p.Article

Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cellsLANXI SONG; TURKSON, James; KARRAS, James G et al.Oncogene (Basingstoke). 2003, Vol 22, Num 27, pp 4150-4165, issn 0950-9232, 16 p.Article

Novel and selective spiroindoline-based inhibitors of sky kinasePOWELL, Noel A; KOHRT, Jeffrey T; SCHWENDE, Frank et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 1, pp 190-193, issn 0960-894X, 4 p.Article

The kinomes of apicomplexan parasitesMIRANDA-SAAVEDRA, Diego; GABALDON, Toni; BARTON, Geoffrey J et al.Microbes and infection. 2012, Vol 14, Num 10, pp 796-810, issn 1286-4579, 15 p.Article

Morphological and Hydrodynamic Correlations with Increasing Outflow Facility by Rho-Kinase Inhibitor Y-27632HAIYAN GONG; YANG, Chen-Yuan Charlie.Journal of ocular pharmacology and therapeutics. 2014, Vol 30, Num 2-3, pp 143-153, issn 1080-7683, 11 p.Conference Paper

Inhibition of Kv4.3 by genistein via a tyrosine phosphorylation-independent mechanismHEE JAE KIM; HYE SOOK AHN; BOK HEE CHOI et al.American journal of physiology. Cell physiology. 2011, Vol 69, Num 3, issn 0363-6143, C567-C575Article

The systemic mastocytosis-specific activating cKit mutation D816V can be inhibited by the tyrosine kinase inhibitor AMN107VON BUBNOFF, N; GORANTLA, S. H. P; KANCHA, R. K et al.Leukemia. 2005, Vol 19, Num 9, pp 1670-1671, issn 0887-6924, 2 p.Article

  • Page / 260